¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lytic pathway"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lytic
    ¿ëÇØ-, ¿ëÇØÀ¯¹ß-
  • lytic infection
    ¿ë±Õ°¨¿°
  • lytic reaction
    ¿ë±Õ¹ÝÀÀ, ¿ëÇØ¹ÝÀÀ
  • lytic response
    ¿ëÇØ¹ÝÀÀ
  • accessory pathway
    µ¡Àüµµ·Î, ºÎÀüµµ·Î
  • alternative complement pathway
    ´ëüº¸Ã¼°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î
  • classic complement pathway
    ÀüÇüÀûº¸Ã¼°æ·Î
  • coagulation pathway
    ÀÀ°í°æ·Î
  • extrinsic pathway of coagulation
    ¿ÜÀμºÀÀ°í°æ·Î
  • intrinsic pathway of coagulation
    ³»ÀμºÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • internodal pathway
    °áÀý°£°æ·Î
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • metabolic pathway
    ´ë»ç°æ·Î
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pathway
    °æ·Î, Åë·Î
  • accessory pathway
    µ¡Àüµµ·Î, ºÎÀüµµ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î, »ýÇÕ¼º°úÁ¤
  • metabolic pathway
    ´ë»ç°æ·Î
  • sensory pathway
    °¨°¢·Î
  • visual pathway
    ½Ã°¢°æ·Î
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lytic infection
    ¿ë±Õ¼º°¨¿°
  • lytic reaction
    ¿ë±Õ¹ÝÀÀ, ¿ëÇØ¹ÝÀÀ
  • lytic response
    ¿ëÇØ¹ÝÀÀ
  • lytic strain
    ¿ë±ÕÁÖ
  • accessory pathway
    ºÎÀüµµ·Î
  • alternative complement pathway
    º¸Ã¼´ëü°æ·Î, µµ¿òü´ëü°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î, »ýÇÕ¼º°úÁ¤
  • classic complement pathway
    º¸Ã¼ÀüÇüÀû°æ·Î, µµ¿òüÀüÇüÀû°æ·Î
  • coagulation pathway
    ÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • internodal pathway
    ¸¶µð»çÀ̱æ
  • metabolic pathway
    ´ë»ç°æ·Î
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • pathway
    °æ·Î, Åë·Î
  • pain pathway
    ÅëÁõÀü´Þ·Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infection, lytic
    ¿ë±Õ¼º°¨¿°
  • Embden-Meyerhof pathway
    ¿¥µ§-¸¶À̾î·ÎÇÁ °æ·Î(ÌèÖØ)
  • Lemniscus pathway
    ¸ð´ë°æ·Î(Ù¶ÓáÌèÖØ)
  • accessory pathway
    ºÎÀüµµ·Î.
  • acetate pathway
    ¾Æ¼¼Å×ÀÌÆ® ´ë»ç°æ·Î(¡­ÓÛÞóÌèÖØ).
  • acoustic pathway
    û°¢·Î
  • alternative pathway
    ±³´ë°æ·Î
  • alternative pathway
    º°µµ°æ·Î, ´ëü°æ·Î
  • glucuronic acid pathway
    ±Û·çÄí·Ð»ê°æ·Î.
  • glycolytic pathway
    ÇØ´ç°æ·Î
  • phosphogluconate oxidative pathway
    ±Û·çÄÜ»ê»êÈ­°æ·Î, ÀÎ´ç¿ø»êÈ­°æ·Î(ìÝÓØ ê«ß«ûùÌèÖØ).
  • proximal common pathway
    ±ÙÀ§°øÅë°æ·Î.
  • pyruvate pathway
    ÇÇ·çºê»ê¿°´ë»ç°æ·Î(¡­ß«ç¤ÓÛÞóÌèÖØ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infection, lytic
    ¿ë±Õ¼º°¨¿°
  • lytic factor
    ¿ëÇØÀÎÀÚ(éÁú°ì×í­).
  • lytic infection
    ¿ë±Õ¼º°¨¿°
  • lytic reaction
    ¿ë±Õ¹ÝÀÀ
  • lytic reaction
    ¿ëÇØ¹ÝÀÀ(éÁú°Úãëë), À¶ÇعÝÀÀ.
  • lytic response
    ¿ë±Õ¹ÝÀÀ
  • lytic strain
    ¿ë±ÕÁÖ
  • accessory pathway
    ºÎÀüµµ·Î.
  • acetate pathway
    ¾Æ¼¼Å×ÀÌÆ® ´ë»ç°æ·Î(¡­ÓÛÞóÌèÖØ).
  • acoustic pathway
    û°¢·Î
  • alternative pathway
    ±³´ë°æ·Î
  • alternative pathway
    º°µµ°æ·Î, ´ëü°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°úÁ¤<°æ·Î>(¡­<ÌèÖØ>).
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î(¡­ÌèÖØ).
  • classic pathway
    ÀüÇüÀû °æ·Î
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lytic gland
    À¶ÇØ»ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lytic cycle
    ¿ëÇØÁÖ±â(éÁú°ñÎÑ¢)
  • lytic enzyme
    ¿ëÇØÈ¿¼Ò(éÁú°ý£áÈ)
  • lytic response
    ¿ëÇØ´ëÀÀ(éÁú°Óßëë)
  • lytic virus
    ¿ëÇØ(éÁú°)¹ÙÀÌ·¯½º
  • alternative pathway
    ´ëü°æ·Î(ÓÛôðð¾ÌèÖØ)
  • aminoadipic pathway
    ¾Æ¹Ì³ë¾ÆµðÇÈ °æ·Î(ÌèÖØ)
  • amphibolic pathway
    ¾ç¸é¼º´ë»ç(ÕרüàõÓÛÞó)
  • arginine dihydrolase pathway
    ¾Æ¸£Áö´ÑµðÈ÷µå·Ñ·¹À̽º °æ·Î(ÌèÖØ)
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î(ßæùêà÷ÌèÖØ)
  • branched metabolic pathway
    ºÐÁö´ë»ç°æ·Î(ÝÂò«ÓÛÞóÌèÖØ)
  • central metabolic pathway
    ÁßÃß´ë»ç°æ·Î(ñéõÒÓÛÞóÌèÖØ)
  • C3 pathway
    C3 °æ·Î (ÌèÖØ)
  • C4 pathway
    C4 °æ·Î (ÌèÖØ)
  • cyclic metabolic pathway
    ȸ·Î ´ë»ç°æ·Î(üÞÖØÓÛÞóÌèÖØ)
  • DAP pathway
    "DAP °æ·Î(ÌèÖØ) (ÔÒ) diaminopimelate pathway,"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lytic
    ¿ëÇØÀÇ
  • optic pathway
    ½Ã½Å°æ·Î
  • pathway
    °æ·Î
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
EM Pathway Embden Meyerhof Pathway
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
LU left upper [limb]; loudness unit; Lupron; lytic unit
LyNeF lytic nephritic factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LU Lytic Units
TLF Trypanosome Lytic Factor
AP accessory pathway
ACP Alternative complement pathway
AP Alternative pathway
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lytic factor
    ¿ëÇØ ÀÎÀÚ
  • afferent neural pathway
    ±¸½É¼º ½Å°æ °æ·Î
    ¸»ÃÊ ºÎÀ§·ÎºÎÅÍ ÁßÃ߽Űæ°è·Î Àü´ÞµÇ´Â ½Å°æ ÀÓÆÞ½º.
  • anterolateral pathway
    Àü¿ÜÃø·Î, Àü¿ÜÃø °æ·Î, Àü¿ÜÃø Åë·Î
    Åë°¢, ¿Â°¢, ³Ã°¢ ¹× µÐÇÑ Ã˰¢ µî ¸¹Àº Á¾·ùÀÇ °¨°¢À» Àü´Þ.
  • ascending pain pathway
    »óÇà µ¿Åë Àü´Þ·Î
  • ascending pathway
    »óÇà·Î, »óÇà °æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º °úÁ¤ °æ·Î
  • central pain transmission pathway
    ÁßÃß¼º ÅëÁõ Àü´Þ °æ·Î, ÁßÃß µ¿ÅëÀü´Þ °æ·Î
  • central pathway
    ÁßÃß¼º °æ·Î, ÁßÃß °æ·Î
  • central somatosensory pathway
    ÁßÃß¼º ü¼º °¨°¢ °æ·Î, ÁßÃß Ã¼¼º °¨°¢ °æ·Î
  • central trigeminal sensory pathway
    ÁßÃß¼º »ïÂ÷ ½Å°æ °¨°¢Áö °æ·Î, Á߽ɼº »ïÂ÷ ½Å°æ °¨°¢Áö °æ·Î
  • classical pathway
    ÀüÇüÀû °æ·Î
    Ç׿ø Ç×ü º¹ÇÕ¹°À̳ª º¯¼º ¸é¿ª ±Û·ÎºÒ¸°À¸·Î ÀϾ´Â º¸Ã¼ ¼ººÐÀÇ ¿¬¼âÀû Ȱ¼ºÈ­ÀÇ °æ·Î. Ç×ü´Â ÇÑ ÀÎÀÚ ÀÌ»óÀÇ IgM ¶Ç´Â µÎ ºÐÀÚ ÀÌ»óÀÇ IgGÀÇ Fc ºÎÀ§¿¡¼­ Clq ºÐÀÚÀÇ C ¸»´ÜÃþ ¿©¼¸ °³ÀÇ ±¸»ó ºÎÀ§¿Í °áÇÕÇÏ¿© À̰ÍÀÌ ¹æ¾Æ¼è°¡ µÇ¾î ÈļÓÀÇ º¸Ã¼ ¼ººÐÀÌ È°¼ºÈ­µÈ´Ù.
  • CNS pathway
    ÁßÃß ½Å°æ°è °æ·Î
  • coagulation pathway
    ÀÀ°í °æ·Î
  • common pathway
    °øÅë °æ·Î
  • conscious pathway
    ÀǽÄÀûÀÎ Àüµµ·Î
    ½Äº°¼º Ã˰¢ ¹× ¾Ð°¢ÀÇ Àüµµ·Î¿Í ÀÏÄ¡.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
lytic pathway The steps in the method that a virus takes to complete a lytic cycle, including the production and assembly of progeny viruses with host cell machinery and the destruction of the host cell by rupturing its plasma membrane (lysis), releasing the progeny viruses in the process.
(09 Oct 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Mlt38 lytic transglycosylase <enzyme> Active against poly(murnac-glcnac) strands
Registry number: EC 2.4.-
Synonym: membrane-bound lytic transglycosylase 38-kD, mlt38 protein, mlta gene product
(26 Jun 1999)
direct lytic factor of cobra venom A polypeptide of 62 residues; action on cells is similar to that of melittin in that it promotes disruption of membranes; used as an investigational antirheumatic agent.
Synonym: cobra toxin, direct lytic factor of cobra venom.
(05 Mar 2000)
direct lytic factors most abundant proteins in cobra (naja of the elapids) venom; basic polypeptides of 57 to 62 amino acids with four disulfide bonds and a molecular weight of less than 7000; causes skeletal and cardiac muscle contracture, interferes with neuromuscular and ganglionic transmission, depolarises nerve, muscle and blood cell membranes, thus causing haemolysis.
Synonym: cobramine a; cobramine b; cobra cytotoxin; gamma toxin; membrane-active polypeptide.
(12 Dec 1998)
lytic 1. Pertaining to lysis or to a lysin.
2. Producing lysis.
Origin: Gr. Lysis = dissolution
(18 Nov 1997)
lytic complex <immunology> The large (2000 kD) cytolytic complex formed from complement C5b6789.
See: complement.
(18 Nov 1997)
lytic cycle The general life cycle of a lytic virus, from infection of the host cell, hijacking of the host cells mechanisms, use of the host cells mechanisms to produce viral components, and assembly of the components into progeny viruses, to the destruction of the host cell by rupturing its plasma membrane (lysis) and the release of the progeny viruses so that they can spread and infect other cells.
(09 Oct 1997)
lytic infection The normal cycle of infection of a cell by a virus or bacteriophage, in which mature virus or phage particles are produced and the cell is then lysed.
(18 Nov 1997)
lytic phage A bacteriophage (virus which infects bacteria) that can only follow the lytic pathway to completing its lytic cycle, and does not have the mechanisms to enter the lysogenic pathway.
(09 Oct 1997)
lytic phase A phase of the virus life cycleduring which the virus replicates within the host cell, releasing a new generation of viruses when the infectedcell lyses.
(09 Oct 1997)
lytic virus <virology> A virus which, as part of its life cycle, causes its host cells plasma membrane to rupture (to lyse).
(09 Oct 1997)
alternative oxidase pathway Pathway of mitochondrial electron transport in higher plants, particularly in fruits and seeds, that does not involve cytochrome oxidase and thus is resistant to cyanide.
(18 Nov 1997)
alternative pathway See: complement activation.
(18 Nov 1997)
anabolic pathway <biochemistry> A reaction or series of reactions in a metabolic pathway that synthesise complex molecules from simpler ones, usually requiring the input of energy.
Compare: catabolic pathway.
(09 Oct 1997)
auditory pathway Neural paths and connections within the central nervous system, beginning at the organ of Corti's hair cells, continuing along the eighth nerve, and terminating at the auditory cortex.
(05 Mar 2000)
GABA pathway The pathway that ultimately converts 4-aminobutyrate to succinate; succinate is then converted to alpha-ketoglutarate, via the tricarboxylic acid cycle, which is then acted upon by glutamate dehydrogenase; glutamate is then decarboxylated to reform 4-aminobutyrate; an important pathway for those cells which make this neuroactive molecule.
Synonym: GABA pathway.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lytic
    ¼¼Æ÷¸¦ ¿ëÇØÇÏ´Â;LYSINÀÇ;LYSISÀÇ
  • pathway
    Á¼Àº±æ;¿À¼Ö±æ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á